MP59-14 CROSS-SECTIONAL STUDY ASSESSING UTILIZATION PATTERNS OF COMBINATION INTRAVESICAL GEMCITABINE AND DOCETAXEL IN THE MANAGEMENT OF BLADDER CANCER. (May 2022)